Millennium Management’s CAMP4 Therapeutics CAMP Stock Holding History
Bought
Maintained
Sold
Other funds holding CAMP
Millennium Management's CAMP Position: Q3 2026 in Review
Millennium Management reduced its CAMP4 Therapeutics (CAMP) stake by 35% in Q3 2026, selling an estimated $63.9K and leaving 28,336 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #5738.
Millennium Management first reported a position in CAMP in Q2 2025 and has held it in 6 quarters since. The position peaked at $379K in Q1 2026. 69 funds tracked by Wall St. Rank hold CAMP as of Q3 2026.
- Millennium Management held 28,336 shares of CAMP4 Therapeutics worth $114K as of Q3 2026.
- Millennium Management sold 15,567 CAMP4 Therapeutics shares in Q3 2026, an estimated $63.9K.
- CAMP4 Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #5738 holding.
- Millennium Management first reported a position in CAMP4 Therapeutics in Q2 2025 and has held it in 6 quarters since.
- Millennium Management's CAMP4 Therapeutics position peaked at $379K in Q1 2026.
- 69 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.